Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| EVMN | Evommune | $29.57 | $12.58 | 74.01% | 13.9M | $536M | $13.89$31.19 |
| FGL | Founder Group | $15.85 | $5.95 | 60.10% | 745.1K | $167M | $7.03$162.00 |
| JZXN | Jiuzi | $2.13 | $0.77 | 56.61% | 70.7M | $1.9M | $1.03$312.80 |
| NKTR | Nektar Therapeutics | $54.41 | $17.34 | 46.78% | 409.9K | $754M | $6.48$66.92 |
| EWCZ | European Wax Center | $5.73 | $1.73 | 43.13% | 10.5M | $175M | $2.72$7.60 |
| ESOA | Energy Services Of America | $12.69 | $3.19 | 33.53% | 1.2M | $158M | $7.64$13.20 |
| ICHR | Ichor | $45.30 | $11.19 | 32.81% | 167.8K | $1.2B | $13.12$47.41 |
| SPOG | Themes ETF Trust - Leverage Shares 2x Long Spot Daily ETF | $7.74 | $1.73 | 28.68% | 1.2M | - | $5.75$15.27 |
| NMRA | Neumora Therapeutics | $2.91 | $0.52 | 21.55% | 312.2K | $399M | $0.61$3.25 |
| LMRI | Lumexa Imaging | $13.84 | $2.29 | 19.83% | 671.1K | $1.1B | $9.97$19.45 |
| PEPG | PepGen | $5.60 | $0.93 | 19.81% | 976.7K | $321M | $0.88$7.80 |
| VSTS | Vestis | $8.70 | $1.38 | 18.78% | 6.2M | $966M | $3.98$13.85 |
| LUXE | LuxExperience B.v. | $9.16 | $1.43 | 18.50% | 21.4K | $1.1B | $6.18$12.50 |
| CCCX | Churchill Capital X | $13.03 | $2.03 | 18.45% | 5.6M | $573M | $10.03$27.50 |
| UNF | UniFirst | $236.00 | $36.16 | 18.09% | 26.5K | $3.5B | $147.66$241.49 |
| PLBY | PLBY Group | $2.50 | $0.38 | 17.93% | 4.1M | $228M | $0.90$2.53 |
| SSII | Ss Innovations International | $4.54 | $0.67 | 17.31% | 5.2K | $749M | $3.02$22.42 |
| CGTL | Creative Global Technology | $4.26 | $0.60 | 16.40% | 138.2K | $110M | $0.41$6.52 |
| VTVT | vTv Therapeutics | $36.75 | $5.09 | 16.08% | 2.9K | $125M | $14.00$44.00 |
| SPOT | Spotify Technology | $478.49 | $63.65 | 15.34% | 8.5M | $85B | $405.00$785.00 |
| DDOG | Datadog | $131.22 | $17.21 | 15.10% | 899K | $40B | $81.63$201.69 |
| MBOT | Microbot Medical | $2.12 | $0.28 | 14.95% | 868.5K | $124M | $1.25$4.67 |
| ACOG | Alpha Cognition | $5.52 | $0.60 | 12.20% | 120.1K | $76M | $3.75$11.54 |
| STRO | Sutro Biopharma | $15.59 | $1.61 | 11.48% | 370.9K | $119M | $5.23$19.45 |
Related Articles
Featured Article
Spotify Delivers Another Hit! Stock Jumps 18%
Travis Hoium|Feb 10, 2026
Margins were the big story for Spotify this quarter.
Software Bear Market: 3 Stocks With 47% to 63% Upside, According to Wall Street
Bram Berkowitz|Feb 7, 2026
Many Wall Street analysts still believe software businesses and investment theses are intact.
Software Bear Market: 2 AI Stocks to Buy Before They Soar 102% and 170%, According to Wall Street Analysts
Trevor Jennewine|Feb 3, 2026
Select Wall Street analysts think shares of Datadog and Atlassian are headed much higher in the next year.
2 Cathie Wood Stocks to Buy on the Dip
Prosper Junior Bakiny|Feb 1, 2026
See beyond the near-term headwinds and focus on the long-term upside.
2 Under-the-Radar Artificial Intelligence (AI) Stocks to Watch Closely in February
Anthony Di Pizio|Jan 31, 2026
The artificial intelligence (AI) boom continues to create new opportunities for companies of all sizes.
3 No-Brainer Artificial Intelligence (AI) Stocks to Buy for 2026 With $200 Right Now
Adam Levy|Dec 15, 2025
Not every artificial intelligence (AI) stock has soared to unreasonable new highs.
Up 30% in 2025, Is Spotify Stock a Buying Opportunity for Investors in 2026?
Parkev Tatevosian, CFA|Dec 6, 2025
Investors are hopeful of another good year in 2026.
Is DataDog an Undervalued Stock?
Parkev Tatevosian, CFA|Dec 2, 2025
Valuation is an important consideration when you're making an investment decision.
Spotify Stock Has Soared by 40% in 2025, but Here's 1 Big Reason to Be Cautious Heading Into 2026
Anthony Di Pizio|Nov 15, 2025
Spotify's returns might not be as strong in 2026 as they were in 2025.
Cathie Wood Thinks AI Will Create a $13 Trillion Software Opportunity. 1 Unstoppable Stock to Buy If She's Right.
Anthony Di Pizio|Nov 14, 2025
This artificial intelligence stock just set a new all-time high, but it could still be a solid long-term buy.
